Q2 2020 Holdings
Filed 2020-08-14 | 57 holdings | $218.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $87.8M | 390,000 | 40.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $46.6M | 1,882,722 | 21.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $35.6M | 2,740,000 | 16.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $26.0M | 3,115,537 | 11.9% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $16.0M | 378,788 | 7.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $4.7M | 1,742,112 | 2.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $96.0K | 2,286,891 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $88.8K | 1,484,674 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $83.9K | 1,422,842 | 0.0% |
| Merus N V | COM | N5749R100 | $81.9K | 5,090,571 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $79.6K | 4,026,157 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $76.2K | 11,318,758 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $67.0K | 2,068,098 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $60.3K | 1,944,546 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $57.5K | 2,315,053 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $48.7K | 7,988,053 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $45.9K | 3,226,769 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $45.2K | 2,775,882 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $44.1K | 3,516,851 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $41.8K | 2,367,288 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $37.4K | 7,090,638 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $36.6K | 2,470,678 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $29.6K | 2,149,057 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $28.9K | 1,294,401 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $27.2K | 7,244,262 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $26.5K | 1,088,479 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $25.2K | 798,286 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $23.6K | 8,294,547 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $18.4K | 2,368,392 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $17.6K | 2,392,151 | 0.0% |
| Calliditas Therapeutics AB | SPONSORED ADS | 13124Q106 | $17.5K | 750,000 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $17.1K | 4,130,162 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $15.8K | 17,426,968 | 0.0% |
| Forte Biosciences Inc(TOCAEUR) | COM | 34962G109 | $14.3K | 978,857 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $13.6K | 3,689,203 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $13.4K | 2,038,528 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $12.3K | 1,984,889 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $10.6K | 322,098 | 0.0% |
| Contrafect Corp(CFRXUSD) | COM | 212326300 | $10.2K | 1,600,000 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $9.8K | 2,143,667 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $9.7K | 3,115,382 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $9.4K | 1,010,892 | 0.0% |
| Verastem Inc | COM | 92337C104 | $8.7K | 5,028,994 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $8.6K | 1,799,694 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $8.0K | 6,929,690 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $6.6K | 486,540 | 0.0% |
| Evelo Biosciences Inc | COM | 299734103 | $6.4K | 1,300,000 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $5.3K | 625,000 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $4.6K | 2,018,398 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $4.4K | 3,650,000 | 0.0% |